Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Facilitating the Ease of Transfer and Scientific Continuity
From a single site, Almac is uniquely positioned to provide a full range of scalable services, from non-GMP to GMP development, to clinical supply (Ph I – III) and on into commercialisation.
From the outset, our development scientists work to advance robust formulations and processes that can be scaled-up and are suitable for large-scale commercialisation. With both the development and GMP teams working closely together, we can facilitate a smooth project management process and the continuation of scientific knowledge.